
Mice Model Market by Service (Breeding, Cryopreservation, Genetic Testing), Type (Conditioned/Surgically Modified Mice, Genetically Engineered Mice, Hybrid/Congenic Mice), Technology, Application - Global Forecast 2024-2030
Description
Mice Model Market by Service (Breeding, Cryopreservation, Genetic Testing), Type (Conditioned/Surgically Modified Mice, Genetically Engineered Mice, Hybrid/Congenic Mice), Technology, Application - Global Forecast 2024-2030
The Mice Model Market size was estimated at USD 1.44 billion in 2023 and expected to reach USD 1.56 billion in 2024, at a CAGR 8.34% to reach USD 2.54 billion by 2030.The use of mice models in life sciences research has become essential for learning a variety of human diseases as well as for creating and testing potential novel treatments. Various models are used; however, mice are particularly helpful as they share many human diseases and mammalian characteristics with humans. The rising cases of immune disease, cancer, and rare diseases have raised the need for adequate research activities, which has enhanced the usage of mouse models. However, the associated limitation and strict regulations and laws for animal models have restricted the use of mice models, which can hamper market development. Despite this, the increasing adoption of advanced technologies like AI and ML, coupled with the rising utilization of non-invasive assessment techniques on mice models, is anticipated to generate highly profitable opportunities for market expansion in the projected timeframe.
Regional Insights
The mice model market is significantly growing in the Americas due to continuous research activities by research organizations and pharmaceutical companies. Moreover, federal government support in terms of grants and investment for drug development and vaccine development has enhanced the scope of the mice model market. In addition, the rising genetic disease and neurological complications in European countries have increased the utilization of mouse models to understand age-related diseases. Moreover, emerging clinical research institutes and favorable government initiatives drive market development in the EMEA region. The rising need for personalized medications, surging geriatric disease, increasing cases of immune disease, and growing prevalence of infectious disease boost the adoption of mice models across the Americas and Europe regions. Furthermore, the presence of major players and ongoing developments of advanced technology in clinical trials is expected to create lucrative scope for the market. On the other hand, the Asia-Pacific region witnesses significant growth prospects of the mice models market in the forecast period due to growing research activities and government initiatives for clinical activities.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Mice Model Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Mice Model Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Mice Model Market, highlighting leading vendors and their innovative profiles. These include Applied StemCell, Inc., Aragen Life Sciences Ltd., Biocytogen Boston Corporation, Charles River Laboratories International, Inc., CompareNetworks, Inc., Creative Biolabs., Crown Bioscience by JSR Life Sciences, LLC, Cyagen US Inc. by PolyGene AG, Envigo by Inotiv, Inc., GenOway, Harbour BioMed, Horizon Discovery Ltd. by PerkinElmer, Inc., inGenious Targeting Laboratory, Inc., ITR Laboratories Canada, Janvier Labs, Marshall BioResources, MD Biosciences, Mirimus, Inc., Oncodesign, SA, Ozgene Pty Ltd., PhoenixBio Co., Ltd., Shanghai Model Organisms Center, Inc., Taconic Biosciences, Inc., The Jackson Laboratory, TransCure bioServices, Translational Drug Development, LLC, Transnetyx, Inc., Urosphere SAS, Vivo Bio Tech Ltd., and XenOPAT SL by Bellvitge Biomedical Research Institute.
Market Segmentation & Coverage
This research report categorizes the Mice Model Market to forecast the revenues and analyze trends in each of the following sub-markets:
Service
Breeding
Cryopreservation
Genetic Testing
Model In-Licensing
Quarantine
Type
Conditioned/Surgically Modified Mice
Genetically Engineered Mice
Hybrid/Congenic Mice
Inbred Mice
Outbred Mice
Technology
CRISPER
Embryonic Stem Cell Injection
Genetically Modified Sperm-Mediated Gene Transfer
Liposome-Mediated DNA & Electroporation of DNA
Microinjection
Nuclear Transfer
TALENs & ZFNs
Application
Cardiovascular Studies
Central Nervous System Studies
Diabetes Studies
Immunology & Inflammation Studies
Oncology Studies
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Mice Model Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Mice Model Market?
3. What are the technology trends and regulatory frameworks in the Mice Model Market?
4. What is the market share of the leading vendors in the Mice Model Market?
5. Which modes and strategic moves are suitable for entering the Mice Model Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
184 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Mice Model Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Escalating use of mice models for drug testing and research of immune disease, cancer and rare disease
- 5.1.1.2. Growing consumption of personalized medicine driving the demand for humanized mice models
- 5.1.1.3. Rising investments and grants coupled with surging pharmaceutical R&D activities
- 5.1.2. Restraints
- 5.1.2.1. Associated limitations with mice models
- 5.1.3. Opportunities
- 5.1.3.1. Emerging implementation of AI and ML in mice modeling
- 5.1.3.2. Improvements in non-invasive assessment of HFpEF in mouse model
- 5.1.4. Challenges
- 5.1.4.1. Stringent regulations and laws considering the ethical use of animals in research
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Mice Model Market, by Service
- 6.1. Introduction
- 6.2. Breeding
- 6.3. Cryopreservation
- 6.4. Genetic Testing
- 6.5. Model In-Licensing
- 6.6. Quarantine
- 7. Mice Model Market, by Type
- 7.1. Introduction
- 7.2. Conditioned/Surgically Modified Mice
- 7.3. Genetically Engineered Mice
- 7.4. Hybrid/Congenic Mice
- 7.5. Inbred Mice
- 7.6. Outbred Mice
- 8. Mice Model Market, by Technology
- 8.1. Introduction
- 8.2. CRISPER
- 8.3. Embryonic Stem Cell Injection
- 8.4. Genetically Modified Sperm-Mediated Gene Transfer
- 8.5. Liposome-Mediated DNA & Electroporation of DNA
- 8.6. Microinjection
- 8.7. Nuclear Transfer
- 8.8. TALENs & ZFNs
- 9. Mice Model Market, by Application
- 9.1. Introduction
- 9.2. Cardiovascular Studies
- 9.3. Central Nervous System Studies
- 9.4. Diabetes Studies
- 9.5. Immunology & Inflammation Studies
- 9.6. Oncology Studies
- 10. Americas Mice Model Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Mice Model Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa Mice Model Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 13.3.1. New Product Launch & Enhancement
- 13.3.1.1. Transgenic Mouse Models Show Jumping Genes
- 13.3.1.2. NIH Scientists Advance Understanding Of Mpox Through Development Of Mouse Model
- 13.3.1.3. Genetically Modified Mice Pave The Way For Customized Medicine In A Rare Disease
- 13.3.1.4. A Mouse That Roars: Chinese Scientists Create The First Mammal With Fully Reprogrammed Genes
- 13.3.1.5. New Method Of Pancreatic Islet Cryopreservation Is Major Breakthrough For Diabetes Cure
- 13.3.1.6. UCLA Researchers Develop First Human Genomic Transgenic Mouse Model Of Huntington's Disease
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. Applied StemCell, Inc.
- 14.1.2. Aragen Life Sciences Ltd.
- 14.1.3. Biocytogen Boston Corporation
- 14.1.4. Charles River Laboratories International, Inc.
- 14.1.5. CompareNetworks, Inc.
- 14.1.6. Creative Biolabs.
- 14.1.7. Crown Bioscience by JSR Life Sciences, LLC
- 14.1.8. Cyagen US Inc. by PolyGene AG
- 14.1.9. Envigo by Inotiv, Inc.
- 14.1.10. GenOway
- 14.1.11. Harbour BioMed
- 14.1.12. Horizon Discovery Ltd. by PerkinElmer, Inc.
- 14.1.13. inGenious Targeting Laboratory, Inc.
- 14.1.14. ITR Laboratories Canada
- 14.1.15. Janvier Labs
- 14.1.16. Marshall BioResources
- 14.1.17. MD Biosciences
- 14.1.18. Mirimus, Inc.
- 14.1.19. Oncodesign, SA
- 14.1.20. Ozgene Pty Ltd.
- 14.1.21. PhoenixBio Co., Ltd.
- 14.1.22. Shanghai Model Organisms Center, Inc.
- 14.1.23. Taconic Biosciences, Inc.
- 14.1.24. The Jackson Laboratory
- 14.1.25. TransCure bioServices
- 14.1.26. Translational Drug Development, LLC
- 14.1.27. Transnetyx, Inc.
- 14.1.28. Urosphere SAS
- 14.1.29. Vivo Bio Tech Ltd.
- 14.1.30. XenOPAT SL by Bellvitge Biomedical Research Institute
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
- FIGURE 1. MICE MODEL MARKET RESEARCH PROCESS
- FIGURE 2. MICE MODEL MARKET SIZE, 2023 VS 2030
- FIGURE 3. MICE MODEL MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. MICE MODEL MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. MICE MODEL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. MICE MODEL MARKET DYNAMICS
- FIGURE 7. MICE MODEL MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
- FIGURE 8. MICE MODEL MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. MICE MODEL MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 10. MICE MODEL MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
- FIGURE 12. MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. MICE MODEL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 14. MICE MODEL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. AMERICAS MICE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. AMERICAS MICE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. UNITED STATES MICE MODEL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 18. UNITED STATES MICE MODEL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MICE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MICE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. MICE MODEL MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 24. MICE MODEL MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.